CLDI
Calidi Biotherapeutics Inc.
NYSE MKT: CLDI · HEALTHCARE · BIOTECHNOLOGY
$0.22
+7.53% today
Updated 2026-04-30
Market cap
$2.46M
P/E ratio
—
P/S ratio
50.83x
EPS (TTM)
$-5.95
Dividend yield
—
52W range
$0 – $13
Volume
4.3M
Calidi Biotherapeutics Inc. (CLDI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-4.83M | $-7.77M | $-13.21M | $-26.98M | $-19.69M | $-21.29M |
| Capital expenditures | $351000.00 | $206000.00 | $428000.00 | $585000.00 | $16000.00 | $120000.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $968000.00 | $1.33M | $6.14M | $4.81M | $2.96M | $2.11M |
| Free cash flow | $-5.18M | $-7.98M | $-13.64M | $-27.57M | $-19.71M | $-21.41M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | $1.67M | $5.67M |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |